Physician

Dharam Pal Mann, M.D.

According to 2025 Medicare claims, Dharam Mann, M.D. (NPI: 1063463099) practices interventional pain management (ipm) in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Ocean, NJ. This provider's primary affiliated billing organization is GARDEN STATE MEDICAL CENTER, LLC (NPI: 1578807517) and primary practice location at 08759-1003.

Mann's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,129 traditional Medicare patients, billed 52,081 HCPCS/CPT codes, and received $934,003 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,053 prescription claims across 764 beneficiaries totaling $77,059 in drug costs, led by Oxycontin (Oxycodone Hcl). DME data shows 31 claims. Open Payments data shows 9 records totaling $594. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $1,003,135 to $77,059. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,145 and ending at $948.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,655	20,999	$1,184,033
2016	1,501	23,898	$1,318,031
2017	1,736	29,093	$1,421,867
2018	1,800	30,063	$1,495,435
2019	1,739	35,293	$1,446,352
2020	1,352	119,858	$1,420,520
2021	1,031	107,810	$1,462,829
2022	1,079	109,701	$1,230,039
2023	1,250	68,754	$1,153,417
2024	1,129	52,081	$934,003

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,044	7,485	$1,003,135
2016	932	4,831	$679,963
2017	1,042	4,510	$369,191
2018	967	3,542	$291,605
2019	989	3,314	$255,171
2020	899	3,247	$307,757
2021	607	2,015	$169,142
2022	694	2,422	$240,042
2023	820	2,876	$140,728
2024	764	2,053	$77,059

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	183	183	$140,246
2016	172	172	$129,195
2017	307	308	$215,442
2018	409	410	$268,951
2019	303	303	$203,122
2020	109	133	$79,202
2021	16	16	$5,171
2022	55	55	$17,979
2023	89	89	$28,966
2024	31	31	$10,103

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	355	355	$134
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	777	1,632	$105
77002	Fluoroscopic guidance for needle placement	214	394	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	654	1,198	$70
J3300	Injection, triamcinolone acetonide, preservative free, 1 mg	556	41,600	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycontin	Oxycodone Hcl	26	734	$12,231
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	431	10,133	$9,856
Lidocaine	Lidocaine	28	1,440	$4,655
Gabapentin	Gabapentin	298	13,632	$4,043
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	144	3,496	$3,536

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L0650	Lumbar-sacral orthosis, sagittal-coronal control, with rigid anterior and posterior frame/panel(s), posterior extends from sacrococcygeal junction to t-9 vertebra, lateral strength provided by rigid lateral frame/panel(s), produces intracavitary pressure to reduce load on intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated, off-the-shelf	N	31	31	$10,103

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$594	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$1,947,116	SPR Therapeutics, Inc

Explore More Providers

FAQ

What Medicare data is available for Dharam Pal Mann, M.D.?

Tedicare shows public-source Medicare data for Dharam Pal Mann, M.D. (NPI 1063463099), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Dharam Pal Mann, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Dharam Pal Mann, M.D.?

Dharam Pal Mann, M.D. is linked to GARDEN STATE MEDICAL CENTER, LLC (billing NPI 1578807517) in the available physician profile data.

Does Dharam Pal Mann, M.D. have Open Payments data?

Dharam Pal Mann, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.